A St. Louis startup is pioneering a new approach to gene editing in crops, and the National Science Foundation just gave it a ...

Metagenomi Inc. (NASDAQ:MGX) is one of the best young stocks to buy and hold for 5 years. In mid-May, Metagenomi announced ...

The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...

Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...

Fourteen million people worldwide suffer from enlarged hearts, or hypertrophic cardiomyopathy (HCM), a genetic disease that ...

Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how would we even know?

A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment made just for him. Researchers described the case in a new study ...

LLY's move to buy Verve ignites investor interest across gene-editing stocks like CRSP, NTLA and BEAM in a booming M&A year.

Baby saved by gene-editing therapy 'graduates' from hospital, goes home KJ Muldoon was diagnosed with a rare, deadly genetic disease after he was born.

Emerging oligonucleotides and gene editing therapies offer greater precision, long-term efficacy, and improved adherence in comparison to traditional statin therapies. This is especially true for ...

A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment made just for him.

Gene editing helped a desperately ill baby thrive. Scientists say it could someday treat millions Doctors hope the technology can someday help the millions left behind even as genetic medicine has ...